BALL KRISTINE M
SEC Form 4 insider trading activity
BALL KRISTINE M has filed 1 SEC Form 4 filing (7 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 14, 2026.
On the most recent filing, BALL KRISTINE M is listed as Director at Oruka Therapeutics, Inc. Inside the rolling window, BALL KRISTINE M reported no open-market purchases and 1 open-market sale totaling $1.9M in ORKA.
Companies traded
Other insiders at ORKA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BALL KRISTINE M made?
BALL KRISTINE M has filed 1 SEC Form 4 filing (7 transaction rows) across 1 company since 2026.
Which companies does BALL KRISTINE M trade?
BALL KRISTINE M has filed SEC Form 4 disclosures for 1 company, including ORKA.
When was BALL KRISTINE M's most recent SEC Form 4 filing?
BALL KRISTINE M's most recent SEC Form 4 filing on Tracefour is dated Nov 14, 2026.
What is BALL KRISTINE M's total buy and sell value in the current window?
Inside the rolling retention window, BALL KRISTINE M bought $0 and sold $1.9M based on SEC Form 4 filings.
What was BALL KRISTINE M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,000 ORKA shares on 2026-11-12, worth $1.9M, per SEC Form 4 filings.